New Studies
A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Vs. Placebo in Pediatric Patients with Chronic HBV Infection – Sponsored by Gilead
A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination in Adolescents and Children with Chronic HCV Infection (GS1116) - Sponsored by Gilead Sciences, Inc.
A Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection (GS1112) – Sponsored by Gilead Sciences, Inc.
An Open-Label Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Ombitasvir (OBV), Paritaprevir (PTV), Ritonavir (RTV) With or Without Dasabuvir (DSV) and With or Without Ribavirin (RBV) in Pediatric Subjects with Genotype 1 or 4 Chronic Hepatitis C Virus Infection – Sponsored by Abbvie
Ongoing Studies
STOPSC- Studies of Primary Sclerosing Cholangitis – a multi-center database to further the understanding of AIH and PSC in children.
Non-Alcoholic Steatohepatitis Study(NASH) sponsored by the National Institutes of Health (NIH)
Liver Transplantation in HIV+ Children sponsored by the National Institutes of Health (NIH) National Institute Allergy and Infectious Disease
Immunosuppression Withdrawal for Pediatric Living-donor Liver Transplant Recipients with the Department of Health and Human Service
Closed Studies
Interferon +/- Ribavirin for Children with HCV (PEDS-C) sponsored by the National Institutes of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – CLOSED to enrollment
SPLIT--Studies of Pediatric Liver Transplantation, (is a multi-center, prospective study to collect scientific data in pediatric liver transplantation) sponsored by the NIH- CLOSED to enrollment
Pegylated Interferon +/- Ribavirin for Children with HCV (PEDS-C) sponsored by the National Institutes of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)- CLOSED to enrollment
SPLIT--Studies of Pediatric Liver Transplantation, (is a multi-center, prospective study to collect scientific data in pediatric liver transplantation) sponsored by the NIH- CLOSED to enrollment
FOG 1- Functional Outcomes of Liver Transplant (HRQOL) – ancillary study to SPLIT, sponsored by the NIH- CLOSED to enrollment
FOG 2- Functional Outcomes of Liver Transplant (Cognitive Development & School Performance) ancillary study to SPLIT, sponsored by the NIH- CLOSED to enrollment
TONIC-Treatment of Non-alcoholic liver disease in children - sponsored by the NIH- CLOSED to enrollment
CLIC – Longitudinal Study of Genetic Causes or Intrahepatic Cholestasis, a multi-center study investigating PFIC, BRIC, A1AT, Alagille Syndrome, and BAD, Sponsored by the NIH. -CLOSED to enrollment
CLIC-Mito – Longitudinal Study of mitochondrial Hepatopathies, sponsored by the NIH- CLOSED to enrollment
Evaluation of the Pharmacokinetic, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are HBeAG-Positive; sponsored by Bristol-Myers Squibb- CLOSED to enrollment
Pediatric Acute Liver Failure Study (ALF) sponsored by the National Institutes of Health (NIH) CLOSED to enrollment
PROBE - A Prospective Database of Infants with Cholestasis conducted by the Biliary Atresia Research Consortium, sponsored by the National Institute of Diabetes, Digestive, and Kidney Diseases of the National Institutes of Health (NIH)- CLOSED to enrollment
START – A Randomized double-blinded, placebo-controlled trial of corticosteroid therapy following portoenterostomy in infants with biliary atresia (NIH)- CLOSED to enrollment
BASIC – Biliary Atresia Study in Infants and Children (NIH)- CLOSED to enrollment
For more information, please contact:
- Camille Langlois at (415) 476-1756 or via email
- Natasha Feier at (415) 476-1539 or via email